IP Library Granted Patent US 8,606,525
Granted Patent B2
US 8,606,525 · App. 11/285,275 · Granted Dec 10, 2013

Determining useful life of a fluid using inventory information

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,606,525
App. No.
11/285,275
Granted
Dec 10, 2013
Kind
B2
Abstract

A method for determining the remaining time a fluid in a container can be used. The method includes: determining the amount of fluid in the container; and determining the remaining time based on the amount of fluid in the container. Preferably, the step of determining the remaining time is calculated by using the determined amount of fluid and a predetermined first correlation of remaining time vs. amount of fluid in the container. In a preferred embodiment, the fluid is a reagent in a reagent pack used in a diagnostic analyzer. A method for measuring the presence or concentration of an analyte in a sample on an automated diagnostic analyzer includes: providing a reagent storage container on the analyzer; providing a measurement station for taking a measurement of the sample; determining the amount of reagent remaining in a reagent storage container; calculating the remaining time of the reagent by using the determined amount of reagent and a predetermined first correlation of remaining time vs. amount of fluid in the container; if the time the reagent has been in the reagent container is greater than the remaining time, then discarding the reagent, otherwise adding reagent to the sample; and taking a measurement of the sample to determine the presence or concentration of the analyte.

Claims (18)

1. A method for determining the remaining time a reagent in a diagnostic analyzer reagent pack can be used in a diagnostic analyzer, comprising:

determining the amount of reagent in the reagent pack;

providing a predetermined first correlation of remaining time vs. amount of reagent in the reagent pack;

determining the total time the reagent can be used without any change in the volume of the reagent;

subtracting the amount of time the reagent has been in use from the total time to arrive at a normal remaining time the reagent can be used which provides a second correlation of normal remaining time the reagent can be used versus the length of time the reagent has been in use; and

determining the remaining time based on the first correlation, the second correlation and the amount of reagent in the reagent pack;

wherein the first correlation is stored on a computer and the computer calculates the remaining time based on the input of the first correlation and the volume of reagent in the reagent pack, and wherein the reagent is aspirated from the reagent pack with an aspirate/dispense probe.

2. A method as claimed in claim 1 , wherein the amount of reagent is expressed in units of volume.

3. A method as claimed in claim 1 , wherein the amount of reagent is expressed in units of weight.

4. A method as claimed in claim 1 , wherein the computer controlling the method is part of a diagnostic analyzer.

5. A method as claimed in claim 1 , wherein the computer controlling the method is remote from a diagnostic analyzer.

6. A method as claimed in claim 5 , wherein the diagnostic analyzer communicates with the computer through one of an intranet, laboratory information system, or internet.

7. A method as claimed in claim 5 , wherein the diagnostic analyzer communicates with the computer through the internet and the computer sends a warning signal when the remaining time is exceeded.

8. A method as claimed in claim 7 , wherein the computer is at the reagent supplier.

9. A method as claimed in claim 1 , wherein the amount of reagent is determined by the number of tests remaining in the container.

10. A method as claimed in claim 9 , wherein the amount of reagent is determined by a known amount of reagent for a predetermined number of analysis minus the number of analysis already performed.

11. A method as claimed in claim 1 , wherein the amount is determined by the volume of fluid in the reagent pack.

12. A method as claimed in claim 1 , wherein the diagnostic analyzer communicates with the computer through one of an intranet, laboratory information system, or internet.

Assignments (6)
SECURITY AGREEMENT Recorded Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
Reel/Frame 060219/0571 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
SECURITY INTEREST Recorded Jul 3, 2014
From: ORTHO-CLINICAL DIAGNOSTICS, INC; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 033276/0104 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2006
From: JACOBS, MERRIT N.
To: ORTHO-CLINICAL DIAGNOSTICS, INC.
Reel/Frame 017351/0192 →